[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES8104243A1 - Un procedimiento para la preparacion de derivados de imida- zolidina - Google Patents

Un procedimiento para la preparacion de derivados de imida- zolidina

Info

Publication number
ES8104243A1
ES8104243A1 ES490799A ES490799A ES8104243A1 ES 8104243 A1 ES8104243 A1 ES 8104243A1 ES 490799 A ES490799 A ES 490799A ES 490799 A ES490799 A ES 490799A ES 8104243 A1 ES8104243 A1 ES 8104243A1
Authority
ES
Spain
Prior art keywords
general formula
signifies
compound
see diagramm
formula see
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES490799A
Other languages
English (en)
Other versions
ES490799A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES8104243A1 publication Critical patent/ES8104243A1/es
Publication of ES490799A0 publication Critical patent/ES490799A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Control Of Transmission Device (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epoxy Resins (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE IMIDAZOLIDINA, DE FORMULA (I), DONDE X PUEDE SER IMINO U OXIGENO; R REPRESENTA UN GRUPO FENILO SUSTITUIDO. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA GENERAL (II), CON UN COMPUESTO DE FORMULA (III), DONDE R ELEVADO A 4 PUEDE SER HIDROGENO O DIVERSOS RADICALES. SE OBTIENE ASI EL COMPUESTO (IA). ESTE COMPUESTO PUEDE HIDROLIZARSE POSTERIORMENTE. ESTOS DERIVADOS POSEEN ACTIVIDAD ANTIANDROGENICA. *FORMULA*
ES490799A 1979-04-24 1980-04-23 Un procedimiento para la preparacion de derivados de imida- zolidina Granted ES490799A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH383779 1979-04-24

Publications (2)

Publication Number Publication Date
ES8104243A1 true ES8104243A1 (es) 1981-04-16
ES490799A0 ES490799A0 (es) 1981-04-16

Family

ID=4264536

Family Applications (1)

Application Number Title Priority Date Filing Date
ES490799A Granted ES490799A0 (es) 1979-04-24 1980-04-23 Un procedimiento para la preparacion de derivados de imida- zolidina

Country Status (13)

Country Link
EP (1) EP0017976B1 (es)
JP (1) JPS55143974A (es)
KR (1) KR850000719B1 (es)
AT (1) ATE3860T1 (es)
CA (1) CA1135706A (es)
DE (1) DE3063837D1 (es)
DK (1) DK174480A (es)
ES (1) ES490799A0 (es)
FI (1) FI801184A (es)
GR (1) GR67605B (es)
HU (1) HU184271B (es)
NO (1) NO801182L (es)
PT (1) PT71135B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2724169B1 (fr) * 1994-09-06 1997-01-03 Roussel Uclaf Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2715402B1 (fr) * 1994-01-05 1996-10-04 Roussel Uclaf Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
TW521073B (en) * 1994-01-05 2003-02-21 Hoechst Marion Roussel Inc New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
CA2550447A1 (en) 2003-12-19 2005-07-07 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies
NZ550102A (en) 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
PT3100727T (pt) 2006-03-27 2018-11-09 Univ California Modulador do recetor de androgénios para o tratamento de cancro da próstata e doenças associadas ao recetor de androgénios
NZ596260A (en) * 2006-03-29 2013-05-31 Univ California Diarylthiohydantoin compounds
EP2620432A3 (en) 2007-10-26 2013-12-18 The Regents Of the University of California Diarylhydantoin compounds
AU2011218173C1 (en) 2010-02-16 2015-04-16 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
CN109999036A (zh) 2012-09-26 2019-07-12 阿拉贡药品公司 用于治疗非转移性去势抵抗性前列腺癌的抗雄激素
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
AU2018351714A1 (en) 2017-10-16 2020-04-30 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB997037A (en) * 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
US3340070A (en) * 1963-08-23 1967-09-05 Shell Oil Co Artificial sweetening agent
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
IL55774A (en) * 1977-10-28 1982-04-30 Sparamedica Ag Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture

Also Published As

Publication number Publication date
FI801184A (fi) 1980-10-25
EP0017976A2 (de) 1980-10-29
ATE3860T1 (de) 1983-07-15
CA1135706A (en) 1982-11-16
GR67605B (es) 1981-08-31
KR850000719B1 (ko) 1985-05-23
JPS55143974A (en) 1980-11-10
KR830002722A (ko) 1983-05-30
PT71135B (en) 1981-08-07
EP0017976B1 (de) 1983-06-22
DK174480A (da) 1980-10-25
ES490799A0 (es) 1981-04-16
EP0017976A3 (en) 1981-04-01
NO801182L (no) 1980-10-27
PT71135A (en) 1980-05-01
DE3063837D1 (en) 1983-07-28
HU184271B (en) 1984-07-30

Similar Documents

Publication Publication Date Title
ES8104243A1 (es) Un procedimiento para la preparacion de derivados de imida- zolidina
ES483613A1 (es) Procedimiento para la obtencion de esteres de acido fosforo-so
BG38639A3 (en) Method for preparing ester derivatives of 6- beta- hydroxymethylpenicillanic acid
ES478156A1 (es) Un metodo de preparacion de compuestos heterociclicos derivados de hidantoina.
ES8400407A1 (es) "un procedimiento para preparar una 1-r1-5-(3-r'-4-r"-fenil)-6-r-2(1h)-piridinona".
GB1224591A (en) Improvements in or relating to phosphonic acid anhydrides
ES465208A1 (es) Un procedimiento para preparar compuestos de imidazolina
GB1394007A (en) Sulphoximines
GB1276277A (en) 2-chloroethane-(thiono)-phosphonic acid amido compounds, processes for their preparation, and their use for the regulation of plant growth
ES8308870A1 (es) Procedimiento para la preparacion de derivados de acido 5-(4-fenil-1-piperidinil) metil-2,3-dihidro-2-oxo-1h-imidazol-4-carboxilico.
ES446187A1 (es) Un metodo de preparar nuevos compuestos de oxima-eter.
ES8605529A1 (es) Procedimiento para la preparacion de acidos alfa-aminoal- quilfosfonicos y de acidos alfa-aminoalquilfosfinicos
SE8300432D0 (sv) Reaktiva kanelsyraderivat for framstellning av biologiskt aktiva amider
ES465346A1 (es) Procedimiento para preparar imidazoles 4,5-disustituidos.
GB1129209A (en) Tricyclic n-alkylated derivatives of acetamide
ES8305333A1 (es) "procedimiento para la preparacion de nuevas sulfiminas".
ES481486A1 (es) Procedimientos para preparar derivados de acidos 1-pirrol- carboxilixos
ES8403442A1 (es) Un procedimiento de preparacion de 1-2(arilmetil)aril-4-oxociclohexanol-oximas.
GB1526607A (en) Zearalin ethers
EP0041576A4 (en) 1- (2,6-DICHLORPHENYL) -2-QUINOLINONE-IMIN-3-CARBOXYLIC ACID, PRODUCTION OF THE COMPOUND AND CONTAINING PAIN-RELIEFING, ANTI-FLAMMING COMPOSITION.
DE3264330D1 (en) Process for the preparation of cycloalkenon derivatives
ES429245A3 (es) Procedimiento para la preparacion de derivados de 5-fenil-te-trazol.
ES480872A1 (es) Procedimiento para la preparacion de composiciones de 1,2,3 triazolidin-3-onas y tionas como agentes fungicidas.
GB1271137A (en) Pyrazolone derivatives
ES468231A1 (es) Un metodo de preparar un compuesto complejo de una sal meta-lica con un compuesto de imidazol